Elevance Health ... operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members ...
In a report released today, Stephen Baxter from Wells Fargo maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $492.5, with a ...
Mark Kaye, the chief financial officer, said the company took a "very disciplined approach between competitiveness and underwriting." ...
Analyst David Windley from Jefferies maintained a Buy rating on Elevance Health (ELV – Research Report) and increased the price target to ...
Overall, Elevance brought in $175.2 billion in 2024, up 3% year over year, thanks to higher premiums in its insurance plans and growth in health services business Carelon. Full-year profit of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback